Improvement in human immunodeficiency virus-1/acquired immune deficiency syndrome patients’ well-being following administration of “Phyto V7”

Figure 4 Quality of life of study participants based on the Karnofsky score. A: The mean and standard deviation of the Index of Quality of Life score of all study participants and of (B) participants who had a Karnofsky score of 5 or less at the onset of the study; C: The proportions of Karnofsky score at days 0, 30, 60 and 90. The P values of Wilcoxon Signed Rank Tests between each day are shown.